Guide to understanding the PSA - Pharmacy Guild of New Zealand

More documents

Recommendations

Info

and any multi-disciplinary team sharedinformation platforms, or the e-prescribingproject, will come from outside the Envelope.6. High risk/Mental Health and Addiction/Disability Service Users.The statement acknowledges that over thefirst seven months of the PSA, the TransitionPayments make funding for pharmacy to servicethis group relatively stable. During this time,CPSOG will address the issue of at-risk groupsthat may not be adequately catered for underthe new PSA.7. Audit.This statement of purpose acknowledges thatefficient audit is necessary to ensure “fundingarrangements are fair and equitable to allProviders.” As with any funding model, it wouldbe possible for Providers to modify their practiceto gain unfairly at others’ expense. Examplesmight be to register excessive numbers of LTCpatients to gain additional fees or to reducerepeat numbers more than is clinically justified.The whole PSA model will be monitored bythe CPSOG’s Audit Sub-Group for trends, butthree aspects in particular are identified in thestatement. These are:• LTC registrations• initial script numbers• ratio of initial to repeat script numbers.The Statement also goes on to indicate that animportant part of the Audit Sub-Group’s role is toensure that “suitably experienced and qualifiedcommunity pharmacy input is available forclinical audits.”8. Role of the CPSGG and CPSOG.The activities and mandate of these committeesare set out and defined in Part I of theAgreement.9. Evaluation.CPSOG will perform a process and outcomeevaluation.10. Ethical and medico-legal issues.One of the ways the expected reduction in repeatnumbers and the management of prescriptionvolume (D5.1) will be achieved is by communitypharmacists having powers to determine periodsof supply. The statement indicates that this mustbe achievable within legal requirements.11. Term.Halfway through the PSA’s three year term theDHBs and Pharmacy Agents will “review thenext stage”. There is no further elaboration onthis statement within the Agreement. The “nextstage” refers to the period following the currentAgreement.pharmacy guild of new zealandPage 4
Guide to understanding the PsaPart E:Definitions andconstructionThis Part defines wording that is used to refer tothe parties to the Agreement. For example, “We”and “our” refers to the DHB while “You” and“your” refers to the Provider (E1.2). It clarifiesthe construction of some references to help theinterpretation of the Agreement, for example“notice” periods, exclude the day given and includethe day of expiry (E2.1). There is also an alphabeticallist of definitions of expressions that are usedelsewhere in the Agreement and are identified byan initial capital letter (E1.3). Some notable definedexpressions are:Part F:Māori Health and otherpopulation groupsThis Part is largely unchanged from the previousPSA. While it clarifies that there is no preferentialaccess to services on the basis of race (F1.1), it setsout various commitments to address inequalitiesand improve health outcomes in Māori (F2), andany other priority population groups (F5). There areagreements to recognise cultural values (F2), consult(F2) and plan to improve service quality (F3).• ARRC Facility, Provider, Service User andPharmacy Services• Consult• Contribution to Cost Pressure (CCP). This maybe used in the calculation of any increase inthe size of the funding Envelope• Dispensing• Eligible Person• Handling fee. Pharmacy contractors wereable to cross out the second sentence if theydisagreed with it• Long Term Condition, LTC: Access Criteria,Exit Criteria, Pharmacy Services, PharmacyServices Protocol, Service Fee Claim andService Patient Eligibility Assessment Form• Market, Market Share• Named Patient Pharmaceutical Assessment(NPPA), Services A and Services B• Pharmacy Agent• Records• Specific Pharmacy Services (Specific Services)• Transition Payment• Uncontrollable Event.Page 5
Page 1 and 2: Guide tounderstandingthe PSAAn over
Page 3 and 4: Guide to understanding the PsaPart
Page 5: Guide to understanding the Psawork
Page 15 and 16: Guide to understanding the PsaPharm
Page 17 and 18: Guide to understanding the Psaratio
Page 19 and 20: Guide to understanding the PsaA gui

Guide to understanding the PSA - Pharmacy Guild of New Zealand

Create successful ePaper yourself

Delete template?

Save as template?